P/E (MRFY) | Fwd. P/E (12 Mo.) | PEG | 1 Yr. EPS Growth Rate | |
---|---|---|---|---|
CYTK | N/A | N/A | N/A | -41.95% |
CYTK Peer | N/A | N/A | N/A | +18.05% |
Pharmaceuticals: Major Industry | 23.1 | 15.7 | 0.3 | +54.24% |
Health Technology Sector | 32.2 | 21.0 | 0.6 | +117.71% |
S&P 500 Market | 32.2 | 37.6 | 1.1 | +99.02% |
Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | |
---|---|---|---|---|
Mean Estimate | -$1.04 | -$1.13 | -$1.20 | -$0.75 |
Previous Mean | -$1.00 | -$1.13 | -$1.20 | N/A |
Standard Deviation | 0.06 | 0.10 | 0.16 | 0.49 |
Low Estimate | -$1.12 | -$1.33 | -$1.38 | -$1.24 |
High Estimate | -$0.95 | -$0.97 | -$0.99 | -$0.26 |